QFITLIA is an antithrombin-directed small interfering ribonucleic acid indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients aged 12 years and older with hemophilia A or B with or without fac… For the full story, visit the source.
Health
Drug Trials Snapshots: QFITLIA
QFITLIA is an antithrombin-directed small interfering ribonucleic acid indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients aged 12 years and older with hemophilia A or B with or without fac…
By FDA· FDA.gov· 28 days ago· 2 min read
This summary is sourced from FDA.gov. Read the full article at:FDA.gov